MedTrace Logo

Lyric Self-replacement Clinical Investigation

NCT05349981 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2023-07-12

No results posted yet for this study

Summary

This study is designed to investigate the effectiveness and safety of the Phonak Lyric self-replacement procedure, as compared to the HCP-replacement procedure.

Conditions

Interventions

DEVICE

Phonak Lyric self-replacement procedure

The self-replacement procedure is an experimental procedure in which the Lyric user replaces the Lyric devices independently at every other device replacement, using dedicated candidacy, training, and management procedures, conducted by and at the discretion of his/her hearing care provider (HCP).

Sponsors & Collaborators

  • AccuData Solutions

    collaborator UNKNOWN

  • Sonova AG

    lead INDUSTRY

Principal Investigators

  • Grace Gardner, AuD · Sonova USA Inc

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-29
Primary Completion
2023-03-09
Completion
2023-03-09
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05349981 on ClinicalTrials.gov